SIADH induced by Tegretol
Martínez-Bruna, M.S.; Dacosta Rodrígues, G.M.; Agorreta Ruiz, J.J.
Anales de Medicina Interna 8(9): 466
1991
ISSN/ISBN: 0212-7199 PMID: 1958785 Document Number: 383918
Document emailed within 1 workday
Related Documents
Novakovic, M.; Fischer, R.; Eich, P. 2001: Carbamazepine-induced SIADH with clinical signs of delirium Psychiatrische Praxis 28(1): 48-49Tomita, M.; Otsuka, Y.; Iida, R.; Kobayashi, S.; Kuriyama, S.; Hosoya, T. 2005: Syndrome of inappropriate ADH secretion (SIADH) induced by pramipexole in a patient with Parkinson's disease Nihon Jinzo Gakkai Shi 47(5): 531-535
Rattel'-Tamantsev, G.I.; Lisnianskaia, R.I.; Zashman, L.M. 1971: Allergic reaction to Tegretol Klinicheskaia Meditsina 49(8): 145-147
Wilton, T.D. 1974: Tegretol in the treatment of diabetic neuropathy South African Medical Journal 48(20): 869-872
Halbreich, U. 1974: Tegretol dependency and diversion of the sense of taste Israel Annals of Psychiatry and Related Disciplines 12(4): 328-332
Agapova, E.N.; Mikhalev, I.D. 1976: Experience with the tegretol treatment of diabetes insipidus Problemy Endokrinologii 22(2): 35-36
Monaco, F.; Riccio, A.; Furlan, P.M. 1974: Preliminary report on the use of Tegretol sirup in epileptic patients Rivista di Neurologia 44(2): 123-133
Hariprasad, M.K.; Eisinger, R.P. 1980: SIADH in psychosis Journal of Clinical Psychiatry 41(4): 148
Kolstee, H.J. 1983: A patient with disseminated lupus erythematosus caused by the use of carbamazepine (Tegretol) Nederlands Tijdschrift Voor Geneeskunde 127(35): 1588-1590
Lüdtke, J. 1970: Our experience with Tegretol in the treatment of true and symptomatic trigeminal neuralgias Deutsche Stomatologie 20(8): 592-598
Danusevich, I.K.; Korin, M.M.; Nedz'ved', G.K.; Shal'kevich, V.B.; Alpatova, A.I. 1975: Study of the mechanism of action of tegretol in experimental allergic encephalomyelitis Farmakologiia i Toksikologiia 38(2): 210-214
Carlsson, C.; Pettersson, L. 1972: Dysphoric symptoms in chronic alcoholics and the effect of carbamazepine (Tegretol) Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 5(4): 403-405
Pérez-Camarero, E.; Martí, J.; Anton-Aranda, E.; Idígoras, I. 1998: Carbamazepine-related SIADH Revista de Neurologia 27(157): 522
Smejkalová, E.; Smejkal, V.; Frahm, H. 1970: Influence of Tegretol on serum antidiuretic activity in patients with diabetes insipidus Vnitrni Lekarstvi 16(9): 887-891
Roach, N.; Murphy, P. 1982: Bipolar affective disorder: report of a case treated with carbamazepine (Tegretol) Journal of the Kansas Medical Society 83(9): 418-9 423
Maesaka, J.K.; Batuman, V.; Yudd, M.; Salem, M.; Sved, A.F.; Venkatesan, J. 1990: Hyponatremia and hypouricemia: differentiation from SIADH Clinical Nephrology 33(4): 174-178
Stoll, E.; Largier, H.; Tönz, O. 1972: Therapy of diabetes insipidus centralis with chlorpropamid (diabinese) and carbamazepin (tegretol) in a child Schweizerische Medizinische Wochenschrift 102(1): 10-14
Peri, A.; Parenti, G.; Giuliani, A.; Scrivano, J.; Pettorini, L.; Festuccia, F.; Pirozzi, N.; Mene', P. 2012: Hyponatremia and syndrome of inappropriate ADH secretion (SIADH) Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 29(6): 661-673
Rompel, H.; Bauermeister, P.W. 1970: Aetiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study South African Medical Journal 44(4): 75-80
Romerio, S.C.; Radanowicz, V.; Schlienger, R.G. 2000: SIADH with epileptic seizures and coma in fluoxetine therapy Praxis 89(10): 404-410